Channelopathies as Causes of Sudden Cardiac Death

Peter J. Schwartz, Michael John Ackerman, Arthur A.M. Wilde

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

This article reviews the main clinical aspects of 3 channelopathies: the long QT syndrome, the catecholaminergic polymorphic ventricular tachycardia, and the Brugada syndrome. The text summarizes our views on clinical presentation and diagnosis, on risk stratification, and on therapy. Special attention is given to the progress in the understanding of the genetic bases and on the growing impact of genetics on therapy, which, at least in the case of long QT syndrome, now allows gene-specific management.

Original languageEnglish (US)
Pages (from-to)537-549
Number of pages13
JournalCardiac Electrophysiology Clinics
Volume9
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Channelopathies
Brugada Syndrome
Long QT Syndrome
Sudden Cardiac Death
Genetic Therapy
Genes
Therapeutics
Polymorphic catecholergic ventricular tachycardia
Long QT syndrome type 3

Keywords

  • Brugada syndrome
  • Catecholaminergic polymorphic ventricular tachycardia
  • Genetic testing
  • Ion channels
  • Left cardiac sympathetic denervation
  • Long QT syndrome
  • Ryanodine receptor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Channelopathies as Causes of Sudden Cardiac Death. / Schwartz, Peter J.; Ackerman, Michael John; Wilde, Arthur A.M.

In: Cardiac Electrophysiology Clinics, Vol. 9, No. 4, 01.12.2017, p. 537-549.

Research output: Contribution to journalReview article

Schwartz, Peter J. ; Ackerman, Michael John ; Wilde, Arthur A.M. / Channelopathies as Causes of Sudden Cardiac Death. In: Cardiac Electrophysiology Clinics. 2017 ; Vol. 9, No. 4. pp. 537-549.
@article{b5099d9a989e4716b45b133e8c15d616,
title = "Channelopathies as Causes of Sudden Cardiac Death",
abstract = "This article reviews the main clinical aspects of 3 channelopathies: the long QT syndrome, the catecholaminergic polymorphic ventricular tachycardia, and the Brugada syndrome. The text summarizes our views on clinical presentation and diagnosis, on risk stratification, and on therapy. Special attention is given to the progress in the understanding of the genetic bases and on the growing impact of genetics on therapy, which, at least in the case of long QT syndrome, now allows gene-specific management.",
keywords = "Brugada syndrome, Catecholaminergic polymorphic ventricular tachycardia, Genetic testing, Ion channels, Left cardiac sympathetic denervation, Long QT syndrome, Ryanodine receptor",
author = "Schwartz, {Peter J.} and Ackerman, {Michael John} and Wilde, {Arthur A.M.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.ccep.2017.07.005",
language = "English (US)",
volume = "9",
pages = "537--549",
journal = "Cardiac Electrophysiology Clinics",
issn = "1877-9182",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Channelopathies as Causes of Sudden Cardiac Death

AU - Schwartz, Peter J.

AU - Ackerman, Michael John

AU - Wilde, Arthur A.M.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - This article reviews the main clinical aspects of 3 channelopathies: the long QT syndrome, the catecholaminergic polymorphic ventricular tachycardia, and the Brugada syndrome. The text summarizes our views on clinical presentation and diagnosis, on risk stratification, and on therapy. Special attention is given to the progress in the understanding of the genetic bases and on the growing impact of genetics on therapy, which, at least in the case of long QT syndrome, now allows gene-specific management.

AB - This article reviews the main clinical aspects of 3 channelopathies: the long QT syndrome, the catecholaminergic polymorphic ventricular tachycardia, and the Brugada syndrome. The text summarizes our views on clinical presentation and diagnosis, on risk stratification, and on therapy. Special attention is given to the progress in the understanding of the genetic bases and on the growing impact of genetics on therapy, which, at least in the case of long QT syndrome, now allows gene-specific management.

KW - Brugada syndrome

KW - Catecholaminergic polymorphic ventricular tachycardia

KW - Genetic testing

KW - Ion channels

KW - Left cardiac sympathetic denervation

KW - Long QT syndrome

KW - Ryanodine receptor

UR - http://www.scopus.com/inward/record.url?scp=85034997330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034997330&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2017.07.005

DO - 10.1016/j.ccep.2017.07.005

M3 - Review article

VL - 9

SP - 537

EP - 549

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

SN - 1877-9182

IS - 4

ER -